These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1929159)

  • 21. Lymph node metastasis in stage I ovarian carcinoma.
    Lang JH
    Chin Med J (Engl); 1994 Sep; 107(9):643-7. PubMed ID: 7805453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraperitoneal laparoscopic para-aortic lymphadenectomy as a diagnostic procedure for lymph node recurrence of gynaecological cancers.
    Sanjuán A; Illa M; Torné A; Román SM; Jurado M; Lejarcegui JA; Pahisa J
    Acta Obstet Gynecol Scand; 2007; 86(4):491-5. PubMed ID: 17486474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer.
    Benedetti-Panici P; Greggi S; Maneschi F; Scambia G; Amoroso M; Rabitti C; Mancuso S
    Gynecol Oncol; 1993 Nov; 51(2):150-4. PubMed ID: 8276287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Laparoscopic lumbo-aortic lymphadenectomy in early-stage non-seminomatous germ cell tumors of the testis: Why? How?].
    Leblanc E; Caty A; Dargent D; Querleu D; Mazeman E
    Prog Urol; 2000 Jun; 10(3):379-87. PubMed ID: 10951930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of complete para-aortic lymphadenectomy in endometrial cancer.
    Fujimoto T; Fukuda J; Tanaka T
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):10-4. PubMed ID: 19124998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pelvic and para-aortic lymphadenectomy in primary cancer of the ovary].
    Le Bouëdec G; Fondrinier E; Kauffmann P; Mansoor A; Dauplat J
    Presse Med; 1992 Apr; 21(16):745-9. PubMed ID: 1535131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
    Camara O; Sehouli J
    Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic factors of invasive bladder cancer with lymph node invasion].
    Lacroix B; Rusch P; Cerisier A; Pages A; Armand C; Tostain J
    Prog Urol; 2002 Sep; 12(4):615-20. PubMed ID: 12463120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of retroperitoneal lymphadenectomy on prognosis of patients with epithelial ovarian cancer.
    Wang Z; Xiong Z; Wang S
    Chin Med J (Engl); 2003 Apr; 116(4):588-92. PubMed ID: 12875728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
    Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
    Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current treatment of malignant epithelial tumors of the ovary].
    Michel G; Castaigne D; Morice P
    Ann Chir; 1997; 51(10):1051-7. PubMed ID: 10868026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of lymph node sampling in epithelial carcinoma of the ovary.
    Carnino F; Fuda G; Ciccone G; Iskra L; Guercio E; Dadone D; Conte PF
    Gynecol Oncol; 1997 Jun; 65(3):467-72. PubMed ID: 9190977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of retroperitoneal lymphadenectomy on survival of patients with epithelial ovarian cancer].
    Xiong ZF; Wang ZH; Wang SX
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):77-80. PubMed ID: 12783692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphadenectomy in the surgical management of penile cancer.
    Protzel C; Alcaraz A; Horenblas S; Pizzocaro G; Zlotta A; Hakenberg OW
    Eur Urol; 2009 May; 55(5):1075-88. PubMed ID: 19264390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
    Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
    Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A rational treatment of stage I epithelial ovarian cancer].
    Wang W; Huo R
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):387-9. PubMed ID: 9275407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.